Stock comparison
MiMedx Group
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
MDXG
MiMedx Group
Market cap
$539.18M
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | MDXG | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 57C | 69B | MTD |
| Benjamin Graham | 50D | 65B | MTD |
| Philip Fisher | 54C | 63C | MTD |
| Peter Lynch | 48D | 66B | MTD |
| Joel Greenblatt | 22F | 68B | MTD |
| Charlie Munger | 44D | 74B | MTD |
| Terry Smith | 51D | 70B | MTD |
Side-by-side metrics
| Metric | MDXG | MTD |
|---|---|---|
| Market cap | $539.18M | $22.29B |
| P/E (TTM) | 17.6x | 25.3x |
| EV/EBIT | 6.0x | 21.6x |
| ROIC (TTM) | 10.81% | 36.09% |
| Gross margin | 81.04% | 57.79% |
| Net margin | 7.88% | 21.4% |
| Revenue CAGR 5y | 14.68% | 2.01% |
| EPS CAGR 5y | - | 6.12% |
| Debt / Equity | 0.0x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MDXG leads on
- Revenue CAGR 5y14.68%vs 2.01%+86%
- EV/EBIT6.0xvs 21.6x+72%
- P/E (TTM)17.6xvs 25.3x+30%
- Gross margin81.04%vs 57.79%+29%
MTD leads on
- Debt / Equity-vs 0.0x+100%
- Market cap$22.29Bvs $539.18M+98%
- ROIC (TTM)36.09%vs 10.81%+70%
- Net margin21.4%vs 7.88%+63%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.